| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 25 |
| 1 | METHOTREXATE | 22 |
| 2 | PREDNISONE | 22 |
| 3 | INFLIXIMAB | 17 |
| 4 | PREDNISOLONE | 17 |
| 5 | PREDNISOLONE ORAL | 17 |
| 6 | PREDNISOLONE ORAL SOLUTION | 17 |
| 7 | CYCLOSPORINE | 15 |
| 8 | ERGOCALCIFEROL | 15 |
| 9 | ADALIMUMAB | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SENNOSIDES, DOCUSATE SODIUM | 1 | 0.0250 |
| 1 | PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE | 1 | 0.0012 |
| 2 | MECASERMIN | 1 | 0.0012 |
| 3 | CALCIUM CHLORIDE INJECTION | 3 | 0.0010 |
| 4 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 5 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 6 | BUSULFAN | 9 | 0.0006 |
| 7 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0005 |
| 8 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| 9 | ERGOCALCIFEROL | 15 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 1 | GLP-2 Analog [EPC] | 5 | 0.0004 |
| 2 | Bismuth [EPC] | 1 | 0.0002 |
| 3 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 6 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 15 | 0.0001 |